The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 66 | — | 20.1x | Near average | |
Growth | 25 | -2.8% | 5.6% | Below average | |
Quality | 6 | -236.7% | 7.6% | Below average | |
Safety | 36 | 0.4x | 0.4x | Near average | |
Capital Return | 82 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Agilon Health, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Agilon Health, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Agilon Health (AGL) stock has seen a positive revision in its average target price over the past thirty days, with the consensus rising by 15.03% to reach 53.2 dollars, despite the number of analysts remaining steady at 7. This change reflects an improvement in future outlooks compared to the previous month; however, the current stock price (86.75) is trading at a significant premium that exceeds even the highest target price set by analysts (81 dollars), indicating a clear valuation gap between the stock's market performance and analyst estimates.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.